When Martin Madaus, Ph.D., became president and CEO of Millipore (Mwww.millipore.com) in January 2005, he immediately began to transform the company into a global supplier of life science tools, ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business of Merck KGaA, ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
DC News Now on MSN
Millipore Sigma office building evacuated after fire in Rockville
MONTGOMERY COUNTY, Va. (DC News Now) –The Millipore Sigma office building in Rockville was evacuated after a fire broke out ...
Award-winning UCOE TM technology chosen by Astellas for its research programs BILLERICA, Mass., December 4, 2008 Millipore Corporation (NYSE:MIL) today announced it has entered into a worldwide, ...
While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...
Company believes that direct operations in the country will enable it to more effectively execute its strategy. Millipore has acquired the remaining 60% ownership of its joint venture in ...
Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase ...
Millipore Corporation and Serologicals Corporation have announced that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals for $31.55 per share ...
Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector Agreed transaction valued at approximately € 5.3 billion ...
Bioscience products and services firm Millipore will acquire Serologicals, a specialist in drug discovery equipment and services, for approximately $1.4 billion. Millipore says the acquisition will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback